Pro- and anti-inflammatory cytokine network

The pro- and anti-inflammatory cytokine network is a highly regulated system of signaling proteins that coordinates the host immune response to pathogens and tissue injury (Dinarello, 2000). Pro-inflammatory cytokines, such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), initiate and amplify the inflammatory response to eliminate threats. Conversely, anti-inflammatory cytokines like Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-beta) act as feedback inhibitors to limit tissue damage and promote resolution (Opal & DePalo, 2000). Chronic imbalance in this network, often characterized by a persistent excess of pro-inflammatory signals, is a primary driver of autoimmune and autoinflammatory diseases (Zhang & An, 2007). While the network itself is a physiological system rather than a single molecular target, individual components within the network are major therapeutic targets. Modern biopharmaceuticals, such as monoclonal antibodies and soluble receptors, are designed to selectively inhibit specific nodes of this network to treat conditions like rheumatoid arthritis and inflammatory bowel disease.

Other names

Cytokine networkCytokine cascadeInflammatory cytokine balanceCytokine milieu

Modulation of the network is achieved through the neutralization of specific pro-inflammatory cytokines or the blockade of their cognate receptors to restore immunological equilibrium.